ESC Premium Access

One year survival benefit of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in acute coronary syndrome undergoing PCI according to left ventricular ejection fraction.

Congress Presentation

About the speaker

Doctor Maria Cespon Fernandez

University Hospital Alvaro Cunqueiro, Vigo (Spain)
0 follower

5 more presentations in this session

Should we use beta-blockers in all patients after st-segment elevation acute myocardial infarction?

Speaker: Doctor J. Ferreira (Coimbra, PT)

Thumbnail

Beta-blockers and cardiovascular outcomes in patients hospitalized for acute coronary syndrome without heart failure

Thumbnail

Effects of selective and nonselective beta-blockers on platelet aggregation in patients with acute coronary syndrome: the PLATE-BLOCK study

Speaker: Doctor F. Ilardi (Naples, IT)

Thumbnail

Guideline recommended therapies and clinical outcomes according to the risk for recurrent cardiovascular events after an acute coronary syndrome

Speaker: Doctor Y. Hammer (Petah Tikva, IL)

Thumbnail

The effect of optimal medical therapy on hospital discharge on 3-year mortality after acute myocardial infarction in patients undergoing primary percutaneous intervention

Speaker: Assistant Professor Z. Mehmedbegovic (Belgrade, RS)

Thumbnail

Access the full session

Beta blockers: required in all acute coronary syndromes?

Speakers: Doctor M. Cespon Fernandez, Doctor J. Ferreira, Doctor F. Ilardi, Doctor Y. Hammer, Assistant Professor Z. Mehmedbegovic
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk